Skip to main content
Drugs Made In America Acquisition Corp. (DMAA)
NASDAQ: DMAA · Real-Time Price · USD
10.06
+0.02 (0.20%)
Apr 24, 2025, 4:00 PM EDT - Market closed

DMAA Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 FY 2024
Period Ending
 Dec '24
Cash & Equivalents
0
Cash & Short-Term Investments
0
Prepaid Expenses
0
Total Current Assets
0
Long-Term Deferred Charges
0.55
Total Assets
0.55
Accrued Expenses
0.08
Short-Term Debt
0.66
Other Current Liabilities
0.06
Total Current Liabilities
0.8
Total Liabilities
0.8
Common Stock
0
Additional Paid-In Capital
0.03
Retained Earnings
-0.28
Shareholders' Equity
-0.24
Total Liabilities & Equity
0.55
Total Debt
0.66
Net Cash (Debt)
-0.66
Net Cash Per Share
-0.08
Filing Date Shares Outstanding
33.52
Total Common Shares Outstanding
8.57
Working Capital
-0.79
Book Value Per Share
-0.03
Tangible Book Value
-0.24
Tangible Book Value Per Share
-0.03
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q